Objective:To investigate whether Buthus martensii karsch(Scorpiones),Scolopendra subspinipes mutilans L.Koch(Scolopendra)and Gekko gecko Linnaeus(Gekko)could ameliorate the hypoxic tumor microenvironment and inhibit l...Objective:To investigate whether Buthus martensii karsch(Scorpiones),Scolopendra subspinipes mutilans L.Koch(Scolopendra)and Gekko gecko Linnaeus(Gekko)could ameliorate the hypoxic tumor microenvironment and inhibit lung cancer growth and metastasis by regulating phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin/hypoxia-inducible factor-1α(PI3K/AKT/mTOR/HIF-1α)signaling pathway.Methods:Male C57BL/6J mice were inoculated with luciferase labeled LL/2-luc-M38 cell suspension to develop lung cancer models,with rapamycin and cyclophosphamide as positive controls.Carboxy methyl cellulose solutions of Scorpiones,Scolopendra and Gekko were administered intragastrically as 0.33,0.33,and 0.83 g/kg,respectively once daily for 21 days.Fluorescent expression were detected every 7 days after inoculation,and tumor growth curves were plotted.Immunohistochemistry was performed to determine CD31 and HIF-1αexpressions in tumor tissue and microvessel density(MVD)was analyzed.Western blot was performed to detect the expression of PI3K/AKT/mTOR/HIF-1αsignaling pathway-related proteins.Enzyme-linked immunosorbent assay was performed to detect serum basic fibroblast growth factor(bFGF),transforming growth factor-β1(TGF-β1)and vascular endothelial growth factor(VEGF)in mice.Results:Scorpiones,Scolopendra and Gekko prolonged the survival time and inhibited lung cancer metastasis and expression of HIF-1α(all P<0.01).Moreover,Scorpiones,Scolopendra and Gekko inhibited the phosphorylation of AKT and ribosomal protein S6 kinase(p70S6K)(P<0.05 or P<0.01).In addition,they also decreased the expression of CD31,MVD,bFGF,TGF-β1 and VEGF compared with the model group(P<0.05 or P<0.01).Conclusion:Scorpiones,Scolopendra and Gekko all showed beneficial effects on lung cancer by ameliorating the hypoxic tumor microenvironment via PI3K/AKT/mTOR/HIF-1αsignaling pathway.展开更多
目的探讨益气通络、健脾补肾法联合穴位贴敷在慢性阻塞性肺疾病(简称慢阻肺)稳定期患者中的应用效果。方法采用随机数字表法将于2020年1月—2021年12月在河北省张家口市中医院接受治疗的180例慢阻肺稳定期患者分为A组、B组和C组,各60例...目的探讨益气通络、健脾补肾法联合穴位贴敷在慢性阻塞性肺疾病(简称慢阻肺)稳定期患者中的应用效果。方法采用随机数字表法将于2020年1月—2021年12月在河北省张家口市中医院接受治疗的180例慢阻肺稳定期患者分为A组、B组和C组,各60例。3组均给予常规西医治疗,A组给予穴位贴敷治疗,B组给予益气通络、健脾补肾方治疗,C组给予益气通络、健脾补肾法联合穴位贴敷治疗。3组均持续治疗9个月。比较治疗9个月后的临床疗效,治疗前、治疗9个月后的6min步行距离(6 min walking distance,6MWD)、劳累程度、生活质量、呼吸困难指数、血气指标及炎性因子。结果治疗9个月后,C组总有效率为88.33%(53/60),高于A、B组的55.00%(33/60)、73.00%(44/60),B组高于A组(P<0.05)。与治疗前比较,治疗9个月后,3组6 MWD均延长,且C组长于A、B组,B组长于A组;劳累评估量表(Borg)评分、慢阻肺患者评估测试(COPD patient assessment test,CAT)评分、改良英国医学研究会呼吸困难指数(modified British medical research council,mMRC)、动脉血二氧化碳分压(PaCO_(2))、血清白细胞介素-8(interleukin-8,IL-8)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)及C反应蛋白(C-reactive protei,CRP)水平均降低,且C组低于A、B组,B组低于A组;3组血氧饱和度(SpO_(2))、动脉血氧分压(PaO_(2))均升高,且C组高于A、B组,B组高于A组(P<0.05),而3组酸碱度(pH)治疗前后及组间比较,差异无统计学差异(P>0.05)。结论益气通络、健脾补肾法联合穴位贴敷可有效缓解慢阻肺稳定期患者呼吸困难症状,减轻患者劳累程度及炎症反应,并改善患者血气指标,提高患者步行能力及生活质量,进而提高治疗效果。展开更多
基金Supported by the Special Scientific Research Project of the Chinese Medicine Industry of the State Administration of Traditional Chinese Medicine of China(No.201307006)National Natural Science Foundation of China(No.82104656,82004179,82074405)Fundamental Research Funds for the Central Public Welfare Research Institutes(No.ZZ14-YQ-013,ZZ15-YQ-024)。
文摘Objective:To investigate whether Buthus martensii karsch(Scorpiones),Scolopendra subspinipes mutilans L.Koch(Scolopendra)and Gekko gecko Linnaeus(Gekko)could ameliorate the hypoxic tumor microenvironment and inhibit lung cancer growth and metastasis by regulating phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin/hypoxia-inducible factor-1α(PI3K/AKT/mTOR/HIF-1α)signaling pathway.Methods:Male C57BL/6J mice were inoculated with luciferase labeled LL/2-luc-M38 cell suspension to develop lung cancer models,with rapamycin and cyclophosphamide as positive controls.Carboxy methyl cellulose solutions of Scorpiones,Scolopendra and Gekko were administered intragastrically as 0.33,0.33,and 0.83 g/kg,respectively once daily for 21 days.Fluorescent expression were detected every 7 days after inoculation,and tumor growth curves were plotted.Immunohistochemistry was performed to determine CD31 and HIF-1αexpressions in tumor tissue and microvessel density(MVD)was analyzed.Western blot was performed to detect the expression of PI3K/AKT/mTOR/HIF-1αsignaling pathway-related proteins.Enzyme-linked immunosorbent assay was performed to detect serum basic fibroblast growth factor(bFGF),transforming growth factor-β1(TGF-β1)and vascular endothelial growth factor(VEGF)in mice.Results:Scorpiones,Scolopendra and Gekko prolonged the survival time and inhibited lung cancer metastasis and expression of HIF-1α(all P<0.01).Moreover,Scorpiones,Scolopendra and Gekko inhibited the phosphorylation of AKT and ribosomal protein S6 kinase(p70S6K)(P<0.05 or P<0.01).In addition,they also decreased the expression of CD31,MVD,bFGF,TGF-β1 and VEGF compared with the model group(P<0.05 or P<0.01).Conclusion:Scorpiones,Scolopendra and Gekko all showed beneficial effects on lung cancer by ameliorating the hypoxic tumor microenvironment via PI3K/AKT/mTOR/HIF-1αsignaling pathway.
文摘目的探讨益气通络、健脾补肾法联合穴位贴敷在慢性阻塞性肺疾病(简称慢阻肺)稳定期患者中的应用效果。方法采用随机数字表法将于2020年1月—2021年12月在河北省张家口市中医院接受治疗的180例慢阻肺稳定期患者分为A组、B组和C组,各60例。3组均给予常规西医治疗,A组给予穴位贴敷治疗,B组给予益气通络、健脾补肾方治疗,C组给予益气通络、健脾补肾法联合穴位贴敷治疗。3组均持续治疗9个月。比较治疗9个月后的临床疗效,治疗前、治疗9个月后的6min步行距离(6 min walking distance,6MWD)、劳累程度、生活质量、呼吸困难指数、血气指标及炎性因子。结果治疗9个月后,C组总有效率为88.33%(53/60),高于A、B组的55.00%(33/60)、73.00%(44/60),B组高于A组(P<0.05)。与治疗前比较,治疗9个月后,3组6 MWD均延长,且C组长于A、B组,B组长于A组;劳累评估量表(Borg)评分、慢阻肺患者评估测试(COPD patient assessment test,CAT)评分、改良英国医学研究会呼吸困难指数(modified British medical research council,mMRC)、动脉血二氧化碳分压(PaCO_(2))、血清白细胞介素-8(interleukin-8,IL-8)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)及C反应蛋白(C-reactive protei,CRP)水平均降低,且C组低于A、B组,B组低于A组;3组血氧饱和度(SpO_(2))、动脉血氧分压(PaO_(2))均升高,且C组高于A、B组,B组高于A组(P<0.05),而3组酸碱度(pH)治疗前后及组间比较,差异无统计学差异(P>0.05)。结论益气通络、健脾补肾法联合穴位贴敷可有效缓解慢阻肺稳定期患者呼吸困难症状,减轻患者劳累程度及炎症反应,并改善患者血气指标,提高患者步行能力及生活质量,进而提高治疗效果。
